Yu Yong - Insider Transactions
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost  |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
 GGNLX | Yu Yong | Chief Scientific Officer | Aug 04 '26 | Sale | 2.94 | 653 | 1,922 | 268,371 | Aug 04 08:20 PM |
| GGNLX | Yu Yong | Chief Scientific Officer | May 11 '26 | Sale | 2.97 | 605 | 1,798 | 149,706 | May 12 08:30 PM |
| GGNLX | Yu Yong | SVP, Clinical Development | Mar 24 '26 | Sale | 2.42 | 906 | 2,193 | 144,938 | Mar 26 05:00 PM |
| GGNLX | Yu Yong | SVP, Clinical Development | Aug 21 '25 | Sale | 3.36 | 3,219 | 10,807 | 146,817 | Dec 11 08:50 PM |
| GGNLX | Yu Yong | SVP, Clinical Development | Nov 17 '25 | Sale | 5.37 | 973 | 5,224 | 145,844 | Dec 11 08:50 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | May 12 '25 | Sale | 2.92 | 5,579 | 16,291 | 47,640 | May 13 05:05 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Jun 24 '24 | Sale | 2.12 | 6,849 | 14,520 | 10,869 | Jul 08 04:30 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Dec 15 '23 | Sale | 13.16 | 32,535 | 428,180 | 0 | Dec 18 04:15 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Dec 07 '23 | Sale | 11.85 | 36,800 | 435,995 | 32,535 | Dec 08 05:57 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Nov 21 '23 | Sale | 10.26 | 18,665 | 191,555 | 69,335 | Nov 22 04:15 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Oct 24 '23 | Option Exercise | 6.00 | 5,200 | 31,200 | 111,335 | Oct 25 04:15 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Oct 24 '23 | Sale | 19.11 | 5,200 | 99,351 | 106,135 | Oct 25 04:15 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Oct 10 '23 | Option Exercise | 6.00 | 5,200 | 31,200 | 111,335 | Oct 11 04:10 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Oct 10 '23 | Sale | 22.01 | 5,200 | 114,462 | 106,135 | Oct 11 04:10 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Sep 26 '23 | Option Exercise | 6.00 | 5,200 | 31,200 | 111,335 | Sep 27 04:10 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Sep 26 '23 | Sale | 23.56 | 5,200 | 122,528 | 106,135 | Sep 27 04:10 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Sep 20 '23 | Option Exercise | 6.00 | 6,000 | 36,000 | 112,135 | Sep 21 04:35 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Sep 20 '23 | Sale | 27.96 | 6,000 | 167,786 | 106,135 | Sep 21 04:35 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Sep 15 '23 | Option Exercise | 6.00 | 10,400 | 62,400 | 116,535 | Sep 18 08:13 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Sep 15 '23 | Sale | 21.89 | 10,400 | 227,630 | 106,135 | Sep 18 08:13 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Sep 13 '23 | Sale | 21.14 | 29,800 | 629,927 | 106,135 | Sep 15 08:06 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Aug 30 '23 | Sale | 24.70 | 19,800 | 489,060 | 135,935 | Aug 30 07:22 PM |
| GGNLX | Yu Yong | VP, Clinical Trial Operations | Aug 18 '23 | Sale | 23.73 | 3,265 | 77,478 | 155,735 | Aug 22 04:14 PM |
